Impact of pharmacological agents on mitochondrial function: a growing opportunity?

Abstract

Present-day drug therapies provide clear beneficial effects as many diseases can be driven into remission and the symptoms of others can be efficiently managed; however, the success of many drugs is limited due to both patient non-compliance and adverse off-target or toxicity-induced effects. There is emerging evidence that many of these side effects are caused by drug-induced impairment of mitochondrial function and eventual mitochondrial dysfunction. It is imperative to understand how and why drug-induced side effects occur and how mitochondrial function is affected. In an aging population, age-associated drug toxicity is another key area of focus as the majority of patients on medication are older. Therefore, with an aging population possessing subtle or even more dramatic individual differences in mitochondrial function, there is a growing necessity to identify and understand early on potentially significant drug-associated off-target effects and toxicity issues. This will not only reduce the number of unwanted side effects linked to mitochondrial toxicity but also identify useful mitochondrial-modulating agents. Mechanistically, many successful drug classes including diabetic treatments, antibiotics, chemotherapies and antiviral agents have been linked to mitochondrial targeted effects. This is a growing area, with research to repurpose current medications affecting mitochondrial function being assessed in cancer, the immune system and neurodegenerative disorders including Parkinson's disease. Here, we review the effects that pharmacological agents have on mitochondrial function and explore the opportunities from these effects as potential disease treatments. Our focus will be on cancer treatment and immune modulation.

Mitochondrial Potassium Channels as Druggable Targets

“…The mitochondria, due to their crucial functions within all mammalian cells, are increasingly considered to be targets in drug development [9][10][11][12]. Targeting mitochondrial potassium channels in various cell types is an important aim of future studies in this context.…”

An Insight into the Mechanism of Holamine- and Funtumine-Induced Cell Death in Cancer Cells

“…Mitochondria play diverse and crucial roles in cell survival and death and are also critical for oncogenesis and the sustained progression of malignant cells. Compounds that target mitochondria are important for the ablation of malignant cells because of their ability to induce excessive reactive oxygen species (ROS), leading to oxidative stress and eventual mitochondrial damage [16]. Cancer cells strive in environments with increased ROS and the concomitant elevation of antioxidant proteins to maintain the requisite oxidation-reduction (REDOX) balance.…”

Update on Calcium Signaling in Cystic Fibrosis Lung Disease

“…The enhancement of mitochondrial quality control through the pharmacological modulation of mitochondrial Ca 2+ signaling is emerging as alternative anti-inflammatory strategy for the prevention or treatment of mitochondrial-associated disorders, such as CF ( Patergnani et al, 2020b ). Drugs that directly affect mitochondria, and thus mitochondrial Ca 2+ signaling, have been recently used as a main mode of action to treat diseases, such as type 2 diabetes and cancer, as well as upregulating the immune system to clear infection with promising success ( Stoker et al, 2019 ).…”